Fineotex Chemical Limited has approved its financial results for FY26 and scheduled its 23rd Annual General Meeting (AGM) for September 11, 2026. The Board of Directors, in a meeting held on August 17, 2026, also approved a proposal to raise funds through the issue of equity shares or other equity-linked securities via permissible modes such as private placement or qualified institutions placement.

The AGM will be conducted through Video Conferencing or Other Audio-Visual Means (OAVM) at 4:00 pm on September 11, 2026. The record date for determining eligibility for the AGM and payment of the final dividend has been fixed as September 4, 2026. Any final dividend declared at the meeting will be paid on or before September 30, 2026.

Corporate Actions and Governance

The Board appointed Mr. Hemant Shetye, Designated Partner of HSPN & Associates LLP, as the Scrutinizer for the 23rd AGM. The notice for the AGM, along with the Director’s Report for FY26, will be available on the company’s website.

Fund Raising Proposal

The company seeks approval from its members and relevant regulatory authorities to raise capital through:

• Private placement
• Preferential issue
• Qualified institutions placement (QIP)
• Further public offer
• Any combination of the above modes

This proposal is subject to applicable regulatory and statutory approvals. The Board meeting commenced at 3:50 pm and concluded at 4:30 pm on August 17, 2026, pursuant to Regulation 30, Regulation 33, and Schedule III (Part A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fineotex Chemical Limited has scheduled a meeting of its Board of Directors for Monday, August 17, 2026, to deliberate on capital raising strategies. The Board will consider the proposal to raise funds by issuing equity shares and/or other equity-linked securities. This move signals the company’s intent to strengthen its capital base, potentially supporting future growth initiatives or debt reduction, though specific allocation details remain undisclosed.

The notice was issued pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sunny Parmar, Company Secretary & Compliance Officer, signed the intimation on August 11, 2026. The company has notified both the Bombay Stock Exchange Limited and The National Stock Exchange of India Limited regarding the scheduled proceedings.

Proposed Fund Raising Modes

The Board is empowered to evaluate multiple avenues for equity financing. The specific modes under consideration include:

The final decision on the mode(s) of issue rests with the Board, contingent upon market conditions and strategic requirements.

Regulatory and Shareholder Approvals

Any resolution passed by the Board is subject to further approvals. The company must secure shareholder approval for the issuance of equity shares. Additionally, regulatory approvals from relevant authorities are required before proceeding with any transaction. The exact quantum of funds to be raised and the pricing mechanism will be determined in subsequent meetings following this initial consideration.

What This Means for Investors

The potential dilution of existing shareholding depends on the volume of new equity issued. Investors should monitor subsequent filings for details on the size of the issue and the identity of potential subscribers. The outcome of this meeting could impact the company’s balance sheet structure and earnings per share metrics in the medium term.